Nektar Therapeutics
XNAS:NKTR
55.93
$56.00 - 900.00
$55.14 - 100.00
$54.66
$61.11
$61.11
$61.11
66.92
6.48
663504
633518.7
20048660.62
Chart
TendieTensor AI Analysis
Company
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
Fundamentals
61
-7.700000
14.114700
-1.87
100
BBG000BHCYJ1
BBG001S7RDK1
19.02M
19.02M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own NKTR. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.